Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
0.7242
-0.0874 (-10.77%)
At close: Oct 7, 2026, 4:00 PM EDT
0.684257
-0.0399 (-5.52%)
After-hours: Oct 7, 2026, 6:00 PM EDT
Actuate Therapeutics Employees
Actuate Therapeutics had 12 employees as of December 31, 2025. The number of employees increased by 2 or 20.00% compared to the previous year. That makes Actuate Therapeutics the world's 39,515th largest employer and 5,899th in the United States.
Employees
12
Change (1Y)
2
Growth (1Y)
20.00%
Revenue / Employee
n/a
Profits / Employee
-$1,704,484
Market Cap
17.39M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 12 | 2 | 20.00% |
| Dec 31, 2024 | 10 | 5 | 100.00% |
| Sep 30, 2024 | 11 | 6 | 120.00% |
| Jun 30, 2024 | 11 | - | - |
| Mar 31, 2024 | 10 | - | - |
| Dec 31, 2023 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| TScan Therapeutics | 138 |
| Jasper Therapeutics | 22 |
| SeaStar Medical Holding | 18 |
| Psyence Biomedical | 12 |
| Cocrystal Pharma | 10 |
| Akari Therapeutics, | 6 |
| Quoin Pharmaceuticals | 6 |
ACTU News
- 1 day ago - Actuate Therapeutics files to sell 50M shares of common stock - TheFly
- 1 day ago - Actuate Therapeutics Registration statement: Registration filing - Filings
- 23 days ago - Actuate Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 4 weeks ago - Actuate to Present at the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 4 weeks ago - Actuate Announces Promising Preclinical Data Showing Synergistic Activity of Elraglusib in Combination with RAS Inhibitors Zoldonrasib and Daraxonrasib - GlobeNewsWire
- 7 weeks ago - Actuate Therapeutics Quarterly report: Q2 2026 - Filings
- 7 weeks ago - Actuate Therapeutics Slides: Corporate presentation - Filings
- 2 months ago - Actuate Therapeutics initiated with a Buy at Rodman & Renshaw - TheFly